Charles River Laboratories (CRL) shares rose over 1% on Wednesday after Morgan Stanley upgraded the stock to overweight from equal weight, and adjusted the price target to $220 from $185
Trading volume stood at over 464,600 shares compared with a daily average of about 855,500.
Price: $186.68, Change: $+1.89, Percent Change: +1.02%